Dapsone Tablet
Product Images NDC 51672-4198

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Dapsone (NDC 51672-4198). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Dapsone 01)

Chemical structure of Dapsone showing two benzene rings connected by a sulfone (SO2) group, each benzene ring with an amino (NH2) group attached.*

FDA Label Image

Principal Display Panel (25 mg Tablet Bottle Label)

Packaging label for Dapsone Tablets, USP 25 mg oral tablets. The label shows a count of 30 tablets and states it is prescription-only (Rx only). Manufacturer details include Taro Pharmaceutical Industries Ltd. and distribution by Taro Pharmaceuticals U.S.A., Inc. Storage and dosage advisories are mentioned as well.*

FDA Label Image

Principal Display Panel (100 mg Tablet Bottle Label)

Label for Dapsone Tablets USP 100 mg, oral tablets, in a package of 30 tablets. The label indicates the product is prescription only and includes storage instructions. It is labeled and distributed by Sun Pharmaceutical Industries, Inc., with manufacturing details from Taro Pharmaceutical Industries Ltd.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.